Through its extracellular and exosomal functions, Gal-3 not only facilitates stromal remodeling and immune escape but also presents a promising dual target for therapies aimed at interrupting tumor spread and restoring antitumor immunity. The gene discussed is LGALS3; the disease is neoplasm.